United Therapeutics(UTHR)
United Therapeutics Corporation is an American publicly traded biotechnology company listed on the NASDAQ under the symbol UTHR. It develops novel, life-extending technologies for patients in the areas of lung disease and organ manufacturing. United Therapeutics is co-headquartered in Silver Spring, Maryland and Research Triangle Park, North Carolina, with additional facilities in Magog and Bromont, Quebec; Melbourne and Jacksonville, Florida; La Jolla, California; and Manchester, New Hampshire.
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
*Currency in USD
Company Revenue
Quarterly
Quarterly
Annual
Annual
Projections
Mock data
Subscribe for the real data
Subscribe for the real data
Revenue by Drug
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name | Drug Name | Approved | Patent Expires | Indication |
|---|---|---|---|---|
| Orenitram | Treprostinil diolamine | 2013-12-20 | 2024-2042 | |
| Remodulin | Treprostinil | 2002-05-21 | 2024-2042 | |
| Tyvaso | Treprostinil | 2009-07-30 | 2024-2042 | |
| Tyvaso dpi | Treprostinil | 2022-05-23 | 2024-2042 | |
| Unituxin | Dinutuximab | 2015-03-10 |
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name | Phase 1 | Phase 2 | Phase 3 | Phase 4 | Indication |
|---|---|---|---|---|---|
1
2
3
>
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use